全文获取类型
收费全文 | 240582篇 |
免费 | 17480篇 |
国内免费 | 6153篇 |
专业分类
耳鼻咽喉 | 1647篇 |
儿科学 | 4076篇 |
妇产科学 | 3334篇 |
基础医学 | 25836篇 |
口腔科学 | 3418篇 |
临床医学 | 23482篇 |
内科学 | 33756篇 |
皮肤病学 | 2424篇 |
神经病学 | 20072篇 |
特种医学 | 8285篇 |
外国民族医学 | 1篇 |
外科学 | 19410篇 |
综合类 | 36367篇 |
一般理论 | 8篇 |
预防医学 | 17669篇 |
眼科学 | 2733篇 |
药学 | 31829篇 |
126篇 | |
中国医学 | 16359篇 |
肿瘤学 | 13383篇 |
出版年
2024年 | 184篇 |
2023年 | 3209篇 |
2022年 | 4927篇 |
2021年 | 9269篇 |
2020年 | 8858篇 |
2019年 | 8077篇 |
2018年 | 8123篇 |
2017年 | 9179篇 |
2016年 | 9134篇 |
2015年 | 8408篇 |
2014年 | 12769篇 |
2013年 | 16690篇 |
2012年 | 13483篇 |
2011年 | 15484篇 |
2010年 | 10462篇 |
2009年 | 10190篇 |
2008年 | 11450篇 |
2007年 | 12514篇 |
2006年 | 11677篇 |
2005年 | 10471篇 |
2004年 | 8858篇 |
2003年 | 7843篇 |
2002年 | 6208篇 |
2001年 | 5565篇 |
2000年 | 4678篇 |
1999年 | 3929篇 |
1998年 | 2958篇 |
1997年 | 2940篇 |
1996年 | 2668篇 |
1995年 | 2456篇 |
1994年 | 2385篇 |
1993年 | 1964篇 |
1992年 | 1794篇 |
1991年 | 1680篇 |
1990年 | 1475篇 |
1989年 | 1204篇 |
1988年 | 1158篇 |
1987年 | 1027篇 |
1986年 | 955篇 |
1985年 | 1356篇 |
1984年 | 1106篇 |
1983年 | 806篇 |
1982年 | 864篇 |
1981年 | 699篇 |
1980年 | 670篇 |
1979年 | 535篇 |
1978年 | 339篇 |
1977年 | 295篇 |
1976年 | 261篇 |
1975年 | 206篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
1.
《Journal of pediatric surgery》2023,58(7):1274-1280
BackgroundPerianal abscesses and anal fistulas are common. The principle of intention-to-treat has not been considered in previous systemic reviews. Thus, the comparison between primary and post-recurrence management was confused, and the recommendation of primary treatment is obscure. The current study aims to identify the optimal initial treatment for pediatric patients.MethodsUsing PRISMA guidelines, studies were identified from MEDLINE, EMBASE, PubMed, Cochrane Library, and Google Scholar without any language or study design restriction. The inclusion criteria include original articles or articles with original data, studies of management for a perianal abscess with or without anal fistula, and patient age of <18 years. Patients with local malignancy, Crohn's disease, or other underlying predisposing conditions were excluded. Studies without analyzing recurrence, case series of <5, and irrelevant articles were excluded in the screening stage. Of the 124 screened articles, 14 articles had no full texts or detailed information. Articles written in a language other than English or Mandarin were translated by Google Translation first and confirmed with native speakers. After the eligibility process, studies that compared identified primary managements were then included in the qualitative synthesis.ResultsThirty-one studies involving 2507 pediatric patients met the inclusion criteria. The study design consisted of two prospective case series of 47 patients and retrospective cohort studies. No randomized control trials were identified. Meta-analyses for recurrence after initial management were performed with a random-effects model. Conservative treatment and drainage revealed no difference (Odds ratio [OR], 1.222; 95% Confidential interval [CI]: 0.615–2.427, p = 0.567). Conservative management had a higher risk of recurrence than surgery without statistical significance (OR 0.278, 95% CI: 0.109–0.707, p = 0.007). Compared with incision/drainage, surgery can prevent recurrence remarkably (OR 4.360, 95% CI: 1.761–10.792, p = 0.001). Subgroup analysis of different approaches within conservative treatment and operation was not performed for lacking information.ConclusionStrong recommendations cannot be made due to the lack of prospective or randomized controlled studies. However, the current study based on real primary management supports initial surgical intervention for pediatric patients with perianal abscesses and anal fistula to prevent recurrence.Level of evidenceType of study: Systemic review; Evidence level: Level II. 相似文献
2.
3.
4.
5.
《Transfusion and apheresis science》2022,61(1):103366
ObjectiveThere is a paucity of data concerning the use of granulocyte colony-stimulating factors (G-CSFs) in pediatric patients with acute lymphoblastic leukemia (ALL). The aim of the present study was to evaluate the effect of G-CSF use on relapse-free and overall survival in 358 consecutive, newly diagnosed pediatric ALL patients uniformly treated at the same institution between April 2012 and April 2020.Materials and MethodsPatients were evaluated in two separate periods, based on the G-CSF treatment approach. All patients who underwent ALL treatment between April 2012 and December 2016 received G-CSF (G-CSF+ arm; n: 245) in the course of the protocol for reducing the risk of febrile neutropenia and/or inducing neutrophil recovery to prevent any treatment delay. No patients after December 2016 received G-CSF, even if they belonged to the high-risk group, and these were included in the G-CSF? arm (n: 113).ResultsEstimated mean relapse-free (106.5 months; 95 % CI 102?110.8 vs 82 months 95 % CI 75.2?88.9; p: 0.794) and overall survival (111.4 months; 95 % CI 108?114.8 vs 85 months 95 % CI 80.4?89.8; p: 0.431) rates were similar between the G-CSF+ and G-CSF? groups.ConclusionsOur findings indicate that G-CSF use during ALL treatment had no effect on relapse rates or overall survival. 相似文献
6.
《Radiography》2022,28(2):353-359
Patient contact shielding has been in use for many years in radiology departments in order to reduce the effects and risks of ionising radiation on certain organs. New technologies in projection imaging and CT scanning such as digital receptors and automatic exposure control (AEC) systems have reduced doses and improved image consistency. These changes and a greater understanding of both the benefits and the risks from the use of shielding have led to a review of shielding use in radiology. A number of professional bodies have already issued guidance in this regard. This paper represents the current consensus view of the main bodies involved in radiation safety and imaging in Europe: European Federation of Organisations for Medical Physics, European Federation of Radiographer Societies, European Society of Radiology, European Society of Paediatric Radiology, EuroSafe Imaging, European Radiation Dosimetry Group (EURADOS), and European Academy of DentoMaxilloFacial Radiology (EADMFR). It is based on the expert recommendations of the Gonad and Patient Shielding (GAPS) Group formed with the purpose of developing consensus in this area. The recommendations are intended to be clear and easy to use. They are intended as guidance, and they are developed using a multidisciplinary team approach. It is recognised that regulations, custom and practice vary widely on the use of patient shielding in Europe and it is hoped that these recommendations will inform a change management program that will benefit patients and staff. 相似文献
7.
目的 通过分析特发性肺纤维化急性加重期(AE-IPF)患者证候与血清生物标志物的关系,为中医辨证治疗提供参考。方法 采用观察性研究设计,收集2019年3月至2019年11月三个中心的AE-IPF患者76例,其中痰热壅肺证26例、痰浊阻肺证50例,并纳入健康志愿者10例作为对照。采用ELISA测定患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平,分析与中医证候的相关性。结果 AE-IPF患者血清CCL18、HMGB1、KL-6、MMP-7、SP-A和SP-D水平均显著高于健康对照组。血清CCL18、HMGB1、KL-6、MMP-7和SP-D水平在痰热壅肺证和痰浊阻肺证患者间无显著性差异(P>0.05),而血清SP-A水平存在显著性差异(P<0.05)。结论 血清SP-A与AE-IPF证候存在一定的相关性,血清SP-A的浓度升高,与痰热壅肺证关系越密切,反之,血清SP-A浓度降低,则与痰浊阻肺证关系越密切。AE-IPF痰热壅肺证患者的预后可能较痰浊阻肺证患者更差。 相似文献
8.
9.
10.